Valdez H - Search Results

1

Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.

Lederman MM, Smeaton L, Smith KY, Rodriguez B, Pu M, Wang H, Sevin A, Tebas P, Sieg SF, Medvik K, Margolis DM, Pollard R, Ertl HC, Valdez H. Lederman MM, et al. Among authors: valdez h. J Infect Dis. 2006 Dec 15;194(12):1677-85. doi: 10.1086/509261. Epub 2006 Nov 2. J Infect Dis. 2006. PMID: 17109339 Clinical Trial.

2

Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.

Lange CG, Lederman MM, Madero JS, Medvik K, Asaad R, Pacheko C, Carranza C, Valdez H. Lange CG, et al. Among authors: valdez h. J Acquir Immune Defic Syndr. 2002 May 1;30(1):33-40. doi: 10.1097/00042560-200205010-00005. J Acquir Immune Defic Syndr. 2002. PMID: 12048361

3

Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.

Rodriguez B, Woolley I, Lederman MM, Zdunek D, Hess G, Valdez H. Rodriguez B, et al. Among authors: valdez h. J Infect Dis. 2003 Feb 1;187(3):504-7. doi: 10.1086/368206. Epub 2003 Jan 24. J Infect Dis. 2003. PMID: 12552436 Clinical Trial.

4

Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.

Valdez H, Mitsuyasu R, Landay A, Sevin AD, Chan ES, Spritzler J, Kalams SA, Pollard RB, Fahey J, Fox L, Namkung A, Estep S, Moss R, Sahner D, Lederman MM. Valdez H, et al. J Infect Dis. 2003 Jan 15;187(2):320-5. doi: 10.1086/346056. Epub 2003 Jan 6. J Infect Dis. 2003. PMID: 12552459 Clinical Trial.

5

Immune restoration with antiretroviral therapies: implications for clinical management.

Lederman MM, Valdez H. Lederman MM, et al. Among authors: valdez h. JAMA. 2000 Jul 12;284(2):223-8. doi: 10.1001/jama.284.2.223. JAMA. 2000. PMID: 10889597

6

[Manifestation of hyper-IgE syndrome in advanced HIV-1 infection].

Lange CG, Gripshover BM, Valdez H, Lederman MM. Lange CG, et al. Among authors: valdez h. Med Klin (Munich). 2002 Jan 15;97(1):34-9. doi: 10.1007/s00063-002-1122-3. Med Klin (Munich). 2002. PMID: 11831060 German.

7

CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.

Lange CG, Valdez H, Medvik K, Asaad R, Lederman MM. Lange CG, et al. Among authors: valdez h. Clin Immunol. 2002 Feb;102(2):154-61. doi: 10.1006/clim.2001.5164. Clin Immunol. 2002. PMID: 11846457

8

GBV-C/HGV infection in HIV-infected patients.

Woolley I, Valdez H, Walker C, Davidson R, Zdunek D, Hess G, Lederman MM. Woolley I, et al. Among authors: valdez h. Clin Microbiol Infect. 1999 Apr;5(4):236-237. doi: 10.1111/j.1469-0691.1999.tb00134.x. Clin Microbiol Infect. 1999. PMID: 11856260 Free article. No abstract available.

9

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.

Valdez H, Connick E, Smith KY, Lederman MM, Bosch RJ, Kim RS, St Clair M, Kuritzkes DR, Kessler H, Fox L, Blanchard-Vargas M, Landay A; AIDS Clinical Trials Group Protocol 375 Team. Valdez H, et al. AIDS. 2002 Sep 27;16(14):1859-66. doi: 10.1097/00002030-200209270-00002. AIDS. 2002. PMID: 12351945

10

Plasma levels of B-lymphocyte stimulator increase with HIV disease progression.

Rodriguez B, Valdez H, Freimuth W, Butler T, Asaad R, Lederman MM. Rodriguez B, et al. Among authors: valdez h. AIDS. 2003 Sep 5;17(13):1983-5. doi: 10.1097/00002030-200309050-00018. AIDS. 2003. PMID: 12960832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page